A sales decline in its contrast media and delivery systems business contributed to a drop in net sales for Mallinckrodt's global medical imaging segment in its 2013 fiscal fourth quarter.
For the period (end-September 27), Mallinckrodt's global medical imaging systems operations had net sales of $229 million, down 5.7% from the $242.8 million reported last year. The firm had $119.6 million in net sales of contrast media and delivery systems, down from $132.7 million a year ago. Mallinckrodt attributed the decrease to continuing commoditization in mature markets such as the U.S. and Western Europe.
Nuclear imaging net sales reached $109.4 million, essentially flat compared with the $110.1 million reported in the fourth quarter of fiscal 2012. Mallinckrodt had $30 million in operating income in the segment, compared with $53.6 million last year.
